Why Pfizer Ignored Data Suggesting Their Drug Could Affect Alzheimer’s

In a controversial pharmaceutical story, this week the Washington Post reported “that Pfizer had evidence that [their drug] Enbrel could be useful in Alzheimer’s disease, and didn’t do anything with it,” according to a blog post from Science magazine: This came from an analysis of insurance claim data: a set of about 127,000 patients with an Alzheimer’s diagnosis and a set…

Is Our Reliance on GPS Shrinking Our Brains?

“Neuroscientists can now see that brain behavior changes when people rely on turn-by-turn directions,” says science writer M.R. O’Connor, citing a study of personal GPS devices co-authored by Kent-based cognitive neuroscience researcher Amir-Homayoun Javadi: What isn’t known is the effect of GPS use on hippocampal function when employed daily over long periods of time. Javadi said the conclusions he draws from…

The Diagnosis Is Alzheimer’s. But That’s Probably Not the Only Problem.

Most people with dementia have a number of brain abnormalities, not just Alzheimer’s disease. The finding is forcing scientists to rethink the search for treatments. Source: https://www.nytimes.com/2019/04/08/health/alzheimers-dementia-stroke.html?partner=rss&emc=rss